Monitoring vital brain signs

Long-term brain pressure monitoring, beyond the ICU

SensoBrain is developing a minimally invasive, electronics-free microfluidic sensor that makes intracranial pressure (ICP) measurable after patients leave the hospital.

Illustration of a brain rendered from luminous signal data

Why ICP matters

Real-time and continuous ICP monitoring is vital to diagnose serious brain conditions

Elevated ICP symptoms

Patients experience nausea, vomiting, headaches, seizures, altered mental status and visual disturbances; elevated ICP could be fatal.

Disease surveillance

ICP elevations signal progression of chronic conditions including hydrocephalus, headaches and brain cancers.

Early intervention

Reducing patient morbidity through long-term ambulatory sensing of ICP, enabling earlier interventions to normalize ICP.

What is SensoBrain?

A passive sensor at the intersection of digital health and precision medicine

SensoBrain is developing an electronics-free, battery-free implantable sensor that makes intracranial pressure measurable outside the intensive care unit — over the long term, without repeated invasive procedures.

Watch the 2-minute overview

Overview video (2023).

Clinical conditions

Where elevated ICP changes outcomes

Elevated ICP is associated with many serious neurological conditions affecting tens of millions of patients worldwide each year.

Initial focus

01

Hydrocephalus

Hydrocephalus is a condition in which there is an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricular system of the brain. The normal flow or absorption of CSF is disrupted, causing it to build up and increase pressure within the skull, which can damage the brain and surrounding tissues.

02

Brain tumors

Many brain tumors cause leaky blood vessels that permit excessive fluid to escape into the brain, causing edema. This can lead to headaches, seizures, nausea and vomiting, and reduced level of consciousness, and could also be fatal.

Future indications

03

Traumatic brain injury

There is a relationship between intracranial hypertension and mortality after severe traumatic brain injury (sTBI). This relationship becomes proportionally greater as ICP increases, with a six-fold increased risk of death when ICP is greater than 40 mm Hg.

04

Stroke & brain hemorrhage

ICP can be a complication of stroke, which occurs when the blood supply to the brain is disrupted, resulting in brain tissue damage. Elevated ICP can put pressure on brain tissue and cause additional damage, potentially leading to neurological deficits and other complications.

05

Idiopathic intracranial hypertension (IIH)

Idiopathic intracranial hypertension causes chronically elevated ICP, leading to severe headaches and risk of permanent vision loss. It primarily affects young women and requires ongoing monitoring.

Our technology

How it works

  1. 01

    Placed during a surgery the patient is already having (shunt placement or tumor resection)

  2. 02

    Read non-invasively through the scalp with an external optical reader, in clinic or at home

  3. 03

    Readings securely uploaded and analyzed

  4. 04

    Clinicians alerted to concerning pressure trends

  5. 05

    Summary reports available for clinical review

Progress

Where we are today

  1. 01

    Stanford Wu Tsai Neurosciences Institute translational grant

  2. 02

    First prototypes implanted in rats — sensor signal read through skin and skull over two weeks

  3. 03

    Core Stanford intellectual property exclusively licensed to SensoBrain

  4. 04

    Built on a proven platform: the same electronics-free microfluidic pressure-sensing principle as Smartlens miLens, now in a U.S. pivotal trial for glaucoma

  5. 05

    SensoBrain incorporated

  6. 06

    HomeLabs Summer Cohort 2026

Value of SensoBrain

At the intersection of digital health, preventive healthcare and precision medicine

Medical

  • Designed to identify patient-specific ICP patterns with AI and machine learning
  • Better understanding of ICP and its relationship with daily activities and other medical conditions

Clinical practice

  • Helps improve patient engagement
  • Designed to reduce unnecessary emergency visits and imaging

Patients

  • Earlier identification of disease progression
  • Fewer hospital visits for pressure checks
  • Monitoring that continues after discharge

Challenges in ICP monitoring

Today's monitoring stops at the ICU door

Current devices

  • Invasive, wired probes
  • Limited to hospital or ICU use
  • Short approved dwell times (days to weeks)
  • Signal drift over time
Illustration of a small passive implantable sensor

Illustration — not the actual device.

SensoBrain device

  • Electronics-free and battery-free
  • Designed for MRI compatibility
  • Designed for long-term implantation
  • Non-invasive readout
  • Placed during existing surgery

Our team

A unique team of experienced scientists, neurologists and engineers

Meet the team

Contact us

For any inquiry, reach out to us

Or email us directly at contact@sensobrain.com.